By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SQI Diagnostics announced today that it has raised C$4.6 million (US$4.6 million) in a private financing.

The Toronto-based molecular diagnostics company raised the funds in a non-brokered private placement of nearly 2.3 million units priced at roughly C$2 per unit, where each unit consisted of a common share and a purchase warrant.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.